NCT06434870

Brief Summary

The QRS-T angle represents a novel marker of myocardial repolarisation. It is defined as the angle difference between the direction of ventricular depolarisation (QRS wave) and the direction of ventricular repolarisation (T wave). It is an indicator of instability in the electrophysiological properties of the myocardium and is associated with arrhythmias. The frontal QRS-T angle is a straightforward, cost-effective parameter that can be readily obtained from 12-lead electrocardiography. The most prevalent arrhythmias during pregnancy are atrial arrhythmias. However, ventricular tachyarrhythmias are exceedingly rare during pregnancy and may be life-threatening. Caesarean section is one of the most common surgical procedures. General anaesthesia, spinal anaesthesia and epidural anaesthesia can be employed in these patients. Spinal anaesthesia is a frequently employed method in caesarean section operations due to its rapid onset of effect, technical simplicity of application and higher probability of success. In pregnant women, anaemia is defined as a haemoglobin concentration below 11 mg/dL in the first trimester, 11 mg/dL in the second trimester and 10.5 mg/dL in the third trimester.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 20, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 22, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 30, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
Last Updated

May 30, 2024

Status Verified

May 1, 2024

Enrollment Period

4 months

First QC Date

May 22, 2024

Last Update Submit

May 22, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • The measurements to be taken include QRS, frontal QRS, QRS angle and Tp-e interval. (T1)

    preoperatively

  • The measurements to be taken include QRS, frontal QRS, QRS angle and Tp-e interval.(T2)

    after spinal anaesthesia

  • The measurements to be taken include QRS, frontal QRS, QRS angle and Tp-e interval.(T3)

    5 min after spinal anaesthesia

  • The measurements to be taken include QRS, frontal QRS, QRS angle and Tp-e interval.(T4)

    5 min after spinal anaesthesia

  • The measurements to be taken include QRS, frontal QRS, QRS angle and Tp-e interval.(T5)

    10 min after spinal anaesthesia

Study Arms (2)

Patients who had undergone Elective Cesarean Surgery with anemia

In pregnant women, haemoglobin values below 11 mg/dL in the first trimester, 11 mg/dL in the second trimester and 10.5 mg/dL in the third trimester indicate anaemia. The group comprised patients with haemoglobin levels below 10.5 mg/dL.

Patients who had undergone Elective Cesarean Surgery without anemia

In pregnant women, haemoglobin values below 11 mg/dL in the first trimester, 11 mg/dL in the second trimester and 10.5 mg/dL in the third trimester indicate anaemia. The group comprised patients with haemoglobin levels above 10.5 mg/dL.

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study will include 100 patients aged 18-45 years with an American Society of Anesthesiologists (ASA) II classification who will undergo elective caesarean section.

You may qualify if:

  • Aged 18-45 years
  • Patients with American Society of Anesthesiologists (ASA) II classification

You may not qualify if:

  • Patients with rhythm disorders
  • Patients with electrolyte disturbances
  • Patients with liver and/or renal failure
  • Obese patients (body mass index \> 30)
  • Trauma patients
  • Cancer patients
  • ASA III-IV patients
  • Patients who do not wish to participate in the study will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Science Turkey Sanliurfa Mehmet Akif Inan Training and Research Hospital

Sanliurfa, 63050, Turkey (Türkiye)

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

May 22, 2024

First Posted

May 30, 2024

Study Start

April 20, 2024

Primary Completion

August 31, 2024

Study Completion

August 31, 2024

Last Updated

May 30, 2024

Record last verified: 2024-05

Locations